Neighborhood Disadvantage Metrics Tied to Stress Genes in Prostate Cancer

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, July 19, 2024 -- Expression of several stress-related genes in prostate tumors is elevated among men residing in disadvantaged neighborhoods, according to a study published online July 12 in JAMA Network Open.

Joseph Boyle, Ph.D., from Virginia Commonwealth University in Richmond, and colleagues examined whether several neighborhood disadvantage metrics are associated with prostate tumor RNA expression of stress-related genes in a cross-sectional study. A total of 105 stress-related genes were assessed with each neighborhood metric for 168 African American and 50 White men with prostate cancer who received radical prostatectomy.

The researchers found that compared with White participants, African American participants experienced greater neighborhood disadvantage (median Area Deprivation Index [ADI], 115 versus 92; median Racial Isolation Index, 0.68 versus 0.11). There was a positive association for ADI with expression of 11 genes; after multiple-comparison adjustment, HTR6 (serotonin pathway) remained significant. Associations were seen for several genes, including HTR6, with multiple metrics. Higher expression of five proinflammatory genes in the Conserved Transcriptional Response to Adversity was seen with greater neighborhood disadvantage.

"These findings support a potential link between neighborhood factors and stress-related pathways, which may in turn contribute to an increased risk of aggressive prostate cancer," the authors write.

One author disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords